Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s15006-024-4411-4 | DOI Listing |
MMW Fortschr Med
November 2024
Klinik für Nephrologie u. Internistische Intensivmedizin, Charité - Univ.-Medizin Berlin/Campus Benjamin Franklin CBF, Hindenburgdamm 30, 12203, Berlin, Germany.
Conscious Cogn
March 2024
Department of Cognitive and Systems Neuroscience, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, Netherland; Research Priority Area, Brain and Cognition, University of Amsterdam, Amsterdam, Netherlands.
How deep is the current diversity in the panoply of theories to define consciousness, and to what extent do these theories share common denominators? Here we first examine to what extent different theories are commensurable (or comparable) along particular dimensions. We posit logical (and, when applicable, empirical) commensurability as a necessary condition for identifying common denominators among different theories. By consequence, dimensions for inclusion in a set of logically and empirically commensurable theories of consciousness can be proposed.
View Article and Find Full Text PDFLeukemia
July 2023
MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.
In parallel to the 5th edition of the World Health Organization Classification of Haematolymphoid Tumours (WHO 2022), an alternative International Consensus Classification (ICC) has been proposed. To evaluate the impact of the new classifications on AML diagnoses and ELN-based risk classification, we analyzed 717 MDS and 734 AML non-therapy-related patients diagnosed according to the revised 4th WHO edition (WHO 2017) by whole genome and transcriptome sequencing. In both new classifications, the purely morphologically defined AML entities decreased from 13% to 5%.
View Article and Find Full Text PDFJ Allergy Clin Immunol
April 2022
Department of Pediatrics, Laboratory for Pediatric Immunology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address:
Background: Public health newborn screening (NBS) programs continuously evolve, taking advantage of international shared learning. NBS for severe combined immunodeficiency (SCID) has recently been introduced in many countries. However, comparison of screening outcomes has been hampered by use of disparate terminology and imprecise or variable case definitions for non-SCID conditions with T-cell lymphopenia.
View Article and Find Full Text PDFFront Immunol
July 2021
Immunology Unit, Department of Biomedical Sciences, Medical School of the University of Barcelona, Barcelona, Spain.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!